Beyond money: the hidden drivers fuelling child food insecurity
Beyond money: the hidden drivers fuelling child food insecurity: New Curtin University research has revealed child food insecurity in developed…
Hippocratic Post
Tobacco and Vapes Bill
Tobacco and Vapes Bill: CIEH welcomes progress of historic legislation which could protect future generations from the harms of smoking.…
How to know if you’re lactose intolerant?
How to know if you're lactose intolerant? Lactose intolerance is one of the most common digestive conditions, affecting millions of people…
Why Looking After Yourself Should Be the New Norm
It seems the norm for us all to be busy in life and not think anything of it. While we…
Broken-heart syndrome patients increased risk
Broken-heart syndrome patients twice as likely to suffer further heart problems: New research from the University of Aberdeen found that…
Effective digital healthcare depends on trust
Effective digital healthcare depends on trust: Digital tools such as telehealth, remote monitoring and mobile health apps are key to…
Natural fats in human skin link to eczema
Natural fats in human skin could explain why some babies develop eczema. An Australian-first study has found that certain natural…
Constipation? BUPA Dr Tim Woodman shares his advice
Are you suffering from constipation? Ahead of Bowel Cancer Awareness Month, Dr Tim Woodman, Medical Director, Policy and Cancer Services,…
NHS England reform must prioritise dentistry
NHS England reform must prioritise dentistry: Comment from Dr Nigel Carter, Chief Executive of the Oral Health Foundation The Prime…
Promising new therapeutic approach for paediatric brain tumours
Paediatric brain tumours remain the most common cause of death from childhood cancer. Paediatric high-grade gliomas (pHGG) in particular are…
NHS approval of endometriosis therapy Ryeqo enhances patient care
NHS approval of endometriosis therapy Ryeqo enhances patient care, eases healthcare strain, says GlobalData. A new endometriosis pill, relugolix combination…
Focus on the gut-liver axis
NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver…